Amneal Pharmaceuticals Non-GAAP EPS of $0.21 beats by $0.03, revenue of $814M beats by $6.68M

Amneal Pharmaceuticals announced its Non-GAAP EPS of $0.21, beating estimates by $0.03, and revenue of $814M, surpassing expectations by $6.68M.